Finance

Beta
Lists
086060:KOSDAQ
GeneBioTech Co Ltd
₩3,895.00
-4.06%
(-165.00) 1D
Jun 10, 3:30:19 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 086060...
Open
₩4,055
High
₩4,055
Low
₩3,880
Mkt. cap
33.54B
Avg. vol.
37.56K
Volume
24.23K
Dividend
1.28%
Quarterly dividend
₩12
Ex-dividend date
Dec 29, 2025
P/E ratio
9.35
52-wk high
₩5,990
52-wk low
₩3,525
EPS
₩417
Shares outstanding
8.61M
No. of employees
42
Open
₩4,055
High
₩4,055
Low
₩3,880
Mkt. cap
33.54B
Avg. vol.
37.56K
Volume
24.23K
Dividend
1.28%
Quarterly dividend
₩12
Ex-dividend date
Dec 29, 2025
P/E ratio
9.35
52-wk high
₩5,990
52-wk low
₩3,525
EPS
₩417
Shares outstanding
8.61M
No. of employees
42
News stories
From sources across the web
About GeneBioTech Co Ltd
CEO-
Employees42
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
23.15B
24.26B
20.54B
21.50B
Cost of goods sold
19.63B
20.22B
17.13B
17.88B
Cost of revenue
19.63B
20.22B
17.13B
17.88B
Research and development expenses
242.93M
-
214.61M
229.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.22B
2.68B
2.13B
2.39B
Operating expense
2.62B
2.68B
2.49B
2.78B
Total operating expenses
22.25B
22.90B
19.62B
20.66B
Operating income
897.00M
1.36B
916.22M
834.98M
Other non operating income
698.84M
-137.62M
19.70M
26.00M
EBT including unusual items
1.44B
1.22B
859.55M
687.39M
EBT excluding unusual items
1.44B
1.22B
859.55M
676.03M
Income tax expense
227.59M
236.17M
30.92M
122.40M
Effective tax rate
15.85%
19.32%
3.60%
17.81%
Other operating expenses
28.06M
-
21.38M
26.02M
Net income
1.21B
986.50M
828.63M
564.99M
Net profit margin
5.22%
4.07%
4.03%
2.63%
Earnings per share
-
-
-
-
Interest and investment income
162.18M
-
194.74M
168.40M
Interest expense
-155.73M
-
-135.14M
-118.06M
Net interest expenses
6.45M
-
59.60M
50.34M
Depreciation and amortization charges
125.30M
-
127.18M
127.32M
EBITDA
1.24B
1.72B
1.26B
1.17B
Gain or loss from assets sale
145.00K
-
-
-11.36M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more